


Searching News Database: Neon Therapeutics
HSMN NewsFeed - 27 Sep 2016
Neon Therapeutics Appoints Oncology Veteran Hugh O’Dowd to Chief Executive Officer
Neon Therapeutics Appoints Oncology Veteran Hugh O’Dowd to Chief Executive Officer
HSMN NewsFeed - 1 Oct 2015
Neon Therapeutics Launches with $55 Million Series A to Develop Neoantigen-based Cancer Immunotherapies
Neon Therapeutics Launches with $55 Million Series A to Develop Neoantigen-based Cancer Immunotherapies
